Meropenem monotherapy as empiric treatment of nosocomial lower respiratory tract infection.
Sieger
B
B
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002442:Ceftazidime / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D016638:Critical Illness / Q000628:therapy; D003428:Cross Infection / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D000077731:Meropenem; D018410:Pneumonia, Bacterial / Q000188:drug therapy*; D012720:Severity of Illness Index; D013845:Thienamycins / Q000627:therapeutic use*; D014031:Tobramycin / Q000627:therapeutic use; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D013845:Thienamycins; D002442:Ceftazidime; D000077731:Meropenem; D014031:Tobramycin